Yu‐Shan Wu

693 total citations
45 papers, 516 citations indexed

About

Yu‐Shan Wu is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Yu‐Shan Wu has authored 45 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 24 papers in Molecular Biology and 12 papers in Infectious Diseases. Recurrent topics in Yu‐Shan Wu's work include Drug Transport and Resistance Mechanisms (22 papers), Cancer therapeutics and mechanisms (18 papers) and HIV/AIDS drug development and treatment (10 papers). Yu‐Shan Wu is often cited by papers focused on Drug Transport and Resistance Mechanisms (22 papers), Cancer therapeutics and mechanisms (18 papers) and HIV/AIDS drug development and treatment (10 papers). Yu‐Shan Wu collaborates with scholars based in Taiwan, United States and China. Yu‐Shan Wu's co-authors include Chung‐Pu Wu, Sung-Han Hsiao, Tai‐Ho Hung, Yang-Hui Huang, Suresh V. Ambudkar, Megumi Murakami, Yanqing Li, Klaus R. Koch, Valerie R. Abratt and H. Klump and has published in prestigious journals such as Advanced Functional Materials, Applied Catalysis B: Environmental and International Journal of Molecular Sciences.

In The Last Decade

Yu‐Shan Wu

43 papers receiving 509 citations

Peers

Countries citing papers authored by Yu‐Shan Wu

Since Specialization

Citations

This map shows the geographic impact of Yu‐Shan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Shan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Shan Wu more than expected).

Fields of papers citing papers by Yu‐Shan Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Shan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Shan Wu. The network helps show where Yu‐Shan Wu may publish in the future.

Co-authorship network of co-authors of Yu‐Shan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Shan Wu. A scholar is included among the top collaborators of Yu‐Shan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Shan Wu. Yu‐Shan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A nested case-control analysis of factors influencing preoperative hospitalization fear in pediatric patients and the alleviating effects of child-friendly visual interventions 2025 ·BMC Pediatrics ·Lei Bian, (unknown), Yu‐Shan Wu, X. Y. Shan	0
2	Vodobatinib overcomes cancer multidrug resistance by attenuating the drug efflux function of ABCB1 and ABCG2 2024 ·European Journal of Pharmacology ·(unknown), (unknown), Megumi Murakami, Yu‐Shan Wu, Tai‐Ho Hung, Chih‐Cheng Chen, Suresh V. Ambudkar, Chung‐Pu Wu	0
3	Enhancing carbon enrichment by metal–organic cage to improve the electrocatalytic carbon dioxide reduction performance of silver-based catalyst 2024 ·Journal of Colloid and Interface Science ·Zhen Zhang, Yao Luo, (unknown), (unknown), Yu‐Shan Wu, (unknown), Yao Wang, Xiang‐Kui Gu, Junchen Xu, Mingyue Ding	3
4	Epertinib counteracts multidrug resistance in cancer cells by antagonizing the drug efflux function of ABCB1 and ABCG2 2024 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), Megumi Murakami, Yu‐Shan Wu, Yang-Hui Huang, Tai‐Ho Hung, Suresh V. Ambudkar, Chung‐Pu Wu	1
5	The colony-stimulating factor-1 receptor inhibitor edicotinib counteracts multidrug resistance in cancer cells by inhibiting ABCG2-mediated drug efflux 2024 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), Megumi Murakami, Yang-Hui Huang, Tai‐Ho Hung, Yu‐Shan Wu, Suresh V. Ambudkar, Chung‐Pu Wu	1
6	ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells 2024 ·International Journal of Molecular Sciences ·Chung‐Pu Wu, (unknown), Megumi Murakami, Yu‐Shan Wu, (unknown), Yang-Hui Huang, Jau‐Song Yu, Suresh V. Ambudkar	1
7	ABCB1 and ABCG2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in Cancer Cell Lines 2023 ·Cells ·Chung‐Pu Wu, (unknown), Ya‐Ju Hsieh, Megumi Murakami, Yang-Hui Huang, (unknown), Tai‐Ho Hung, Jau‐Song Yu, Yu‐Shan Wu, Suresh V. Ambudkar	7
8	Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells 2023 ·International Journal of Molecular Sciences ·Chung‐Pu Wu, (unknown), Megumi Murakami, Sung-Han Hsiao, (unknown), Yang-Hui Huang, Yu‐Tzu Chang, Tai‐Ho Hung, Yu‐Shan Wu, Suresh V. Ambudkar	7
9	P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhibitor Ensartinib in Cancer Cells 2022 ·Cancers ·Chung‐Pu Wu, (unknown), Megumi Murakami, Yu‐Shan Wu, Chun‐Ling Lin, Yang-Hui Huang, Tai‐Ho Hung, Jau‐Song Yu, Suresh V. Ambudkar	11
10	The multi-targeted tyrosine kinase inhibitor SKLB610 resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs 2022 ·Biomedicine & Pharmacotherapy ·Chung‐Pu Wu, Megumi Murakami, Yu‐Shan Wu, Chun‐Ling Lin, Yanqing Li, Yang-Hui Huang, Tai‐Ho Hung, Suresh V. Ambudkar	9
11	Bacteria distribution and drug resistance of co-infection patients of human immunodeficiency virus and nontuberculous mycobacteria in Chongqing 2021 ·Min Liu, Mingjun Li, Qing Yu, Kunlun He, Yu‐Shan Wu, (unknown), Tongxin Li	1
12	Multidrug resistance: The clinical dilemma of refractory Helicobacter pylori infection 2021 ·Journal of Microbiology Immunology and Infection ·Chia‐Jung Kuo, Cheng‐Han Lee, Ming‐Ling Chang, Cheng‐Yu Lin, Wey‐Ran Lin, Ming‐Yao Su, Cheng‐Hsun Chiu, Chi‐Nan Tseng, Yu‐Shan Wu, Cheng‐Tang Chiu, Chih‐Ho Lai	28
13	Branebrutinib (BMS-986195), a Bruton’s Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents 2021 ·Frontiers in Cell and Developmental Biology ·Chung‐Pu Wu, Megumi Murakami, Yu‐Shan Wu, (unknown), Sung-Han Hsiao, Yang-Hui Huang, Tai‐Ho Hung, Suresh V. Ambudkar	9
14	Identification of Prognostic miRNAs Associated With Immune Cell Tumor Infiltration Predictive of Clinical Outcomes in Patients With Non-Small Cell Lung Cancer 2021 ·Frontiers in Oncology ·Yuepeng Zhang, Kai Mi, Zhiheng Li, (unknown), (unknown), Yu‐Shan Wu, (unknown), (unknown)	2
15	Diagnosis of Pneumocystis pneumonia by real-time PCR in patients with various underlying diseases 2019 ·Journal of Microbiology Immunology and Infection ·Shu‐Li Yang, Ying-Hao Wen, Yu‐Shan Wu, (unknown), Pi‐Yueh Chang, (unknown), Jang‐Jih Lu	17
16	SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines 2018 ·Cancer Letters ·Chung‐Pu Wu, Megumi Murakami, Sung-Han Hsiao, (unknown), (unknown), Yanqing Li, Tai‐Ho Hung, Yu‐Shan Wu, Suresh V. Ambudkar	18
17	Synthesis, crystal structures, molecular docking, and in vitro biological activities of transition metals with 4-(2,3-dichlorophenyl)piperazine-1-carboxylic acid 2016 ·Bioorganic & Medicinal Chemistry Letters ·Dandan Yang, Yanan Chen, Yu‐Shan Wu, Rui Wang, Zhijian Chen, Jie Qin, Shao‐Song Qian, Hai‐Liang Zhu	6
18	Antihelminthic niclosamide modulates dendritic cells activation and function 2014 ·Cellular Immunology ·Chieh‐Shan Wu, Yirong Li, Jeremy J.W. Chen, (unknown), Ching‐Liang Chu, (unknown), Yu‐Shan Wu, Chi‐Chen Lin	21
19	Discovery of potent antimicrobial peptide analogs of Ixosin-B 2012 ·Bioorganic & Medicinal Chemistry Letters ·Feng‐Di T. Lung, (unknown), (unknown), (unknown), (unknown), (unknown), Yu‐Shan Wu	14
20	Intercalation into the DNA double helix and in vivo biological activity of water-soluble planar [Pt(diimine)(N,N-dihydroxyethyl-N′-benzoylthioureato)]+Cl− complexes: A study of their thermal stability, their CD spectra and their gel mobility 2005 ·Archives of Biochemistry and Biophysics ·Yu‐Shan Wu, Klaus R. Koch, Valerie R. Abratt, H. Klump	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact